Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.

Terme M, Mignot G, Ullrich E, Bonmort M, Minard-Colin V, Jacquet A, Schultze JL, Kroemer G, Leclerc C, Chaput N, Zitvogel L.

Cancer Res. 2009 Aug 15;69(16):6590-7. doi: 10.1158/0008-5472.CAN-08-4473.

2.

Licensing of killer dendritic cells in mouse and humans: functional similarities between IKDC and human blood γδ T-lymphocytes.

Anderson J, Gustafsson K, Himoudi N.

J Immunotoxicol. 2012 Jul-Sep;9(3):259-66. doi: 10.3109/1547691X.2012.685528. Epub 2012 May 27. Review.

PMID:
22632132
3.

Killer dendritic cells: IKDC and the others.

Bonmort M, Dalod M, Mignot G, Ullrich E, Chaput N, Zitvogel L.

Curr Opin Immunol. 2008 Oct;20(5):558-65. doi: 10.1016/j.coi.2008.04.006. Epub 2008 Jun 12. Review.

PMID:
18554881
4.

The adenylate cyclase toxin from Bordetella pertussis--a novel promising vehicle for antigen delivery to dendritic cells.

Simsova M, Sebo P, Leclerc C.

Int J Med Microbiol. 2004 Apr;293(7-8):571-6. Review.

PMID:
15149033
5.

Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces.

Villadangos JA, Schnorrer P, Wilson NS.

Immunol Rev. 2005 Oct;207:191-205. Review.

PMID:
16181337
6.

Killer dendritic cells: mechanisms of action and therapeutic implications for cancer.

Wesa AK, Storkus WJ.

Cell Death Differ. 2008 Jan;15(1):51-7. Epub 2007 Oct 19. Review.

7.

Dendritic cells presenting tumor antigen.

Shurin MR.

Cancer Immunol Immunother. 1996 Nov;43(3):158-64. Review.

PMID:
9001569
8.

Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response.

Reschner A, Hubert P, Delvenne P, Boniver J, Jacobs N.

Clin Exp Immunol. 2008 May;152(2):219-26. doi: 10.1111/j.1365-2249.2008.03624.x. Epub 2008 Mar 10. Review. Erratum in: Clin Exp Immunol. 2008 Sep;153(3):463.

9.

[Role of dendritic cells in recognizing antigens: their binding, transformation and presentation to T lymphocytes].

Kołodziej D, Pajtasz-Piasecka E.

Postepy Hig Med Dosw. 2003;57(2):149-70. Review. Polish.

PMID:
12866353
10.

Killer dendritic cells and their potential role in immunotherapy.

Ullrich E, Chaput N, Zitvogel L.

Horm Metab Res. 2008 Feb;40(2):75-81. doi: 10.1055/s-2007-1022554. Review.

PMID:
18283624
11.

The cell biology of cross-presentation and the role of dendritic cell subsets.

Lin ML, Zhan Y, Villadangos JA, Lew AM.

Immunol Cell Biol. 2008 May-Jun;86(4):353-62. doi: 10.1038/icb.2008.3. Epub 2008 Feb 12. Review.

PMID:
18268517
12.

Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo.

Villadangos JA, Schnorrer P.

Nat Rev Immunol. 2007 Jul;7(7):543-55. Review.

PMID:
17589544
13.

Therapy-induced tumor immunosurveillance involves IFN-producing killer dendritic cells.

Ullrich E, Bonmort M, Mignot G, Chaput N, Taieb J, Ménard C, Viaud S, Tursz T, Kroemer G, Zitvogel L.

Cancer Res. 2007 Feb 1;67(3):851-3. Review.

14.

Endosomal sorting of MHC class II determines antigen presentation by dendritic cells.

van Niel G, Wubbolts R, Stoorvogel W.

Curr Opin Cell Biol. 2008 Aug;20(4):437-44. doi: 10.1016/j.ceb.2008.05.011. Epub 2008 Jul 5. Review.

PMID:
18582577
15.

Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells.

Lutz MB, Kurts C.

Eur J Immunol. 2009 Sep;39(9):2325-30. doi: 10.1002/eji.200939548. Review.

16.

Regulation of MHC II and CD1 antigen presentation: from ubiquity to security.

Gelin C, Sloma I, Charron D, Mooney N.

J Leukoc Biol. 2009 Feb;85(2):215-24. doi: 10.1189/jlb.0308206. Epub 2008 Sep 22. Review.

PMID:
18809734
17.

Antigen presentation by dendritic cells in vivo.

Segura E, Villadangos JA.

Curr Opin Immunol. 2009 Feb;21(1):105-10. doi: 10.1016/j.coi.2009.03.011. Epub 2009 Apr 1. Review.

PMID:
19342210
18.

Interferon-gamma is produced by another player of innate immune responses: the interferon-producing killer dendritic cell (IKDC).

Bonmort M, Ullrich E, Mignot G, Jacobs B, Chaput N, Zitvogel L.

Biochimie. 2007 Jun-Jul;89(6-7):872-7. Epub 2007 May 5. Review.

PMID:
17574720
19.

The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer.

Seya T, Matsumoto M.

Cancer Immunol Immunother. 2009 Aug;58(8):1175-84. doi: 10.1007/s00262-008-0652-9. Epub 2009 Jan 31. Review.

PMID:
19184005
20.

[Antitumor cellular immunotherapy: the breakthrough of dendritic cells].

Angevin E, André F, Zitvogel L.

Bull Cancer. 2000 Jan;87(1):107-15. Review. French. No abstract available.

Supplemental Content

Support Center